Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析

MarketLineが発行した調査報告書(SWOT20MY5029)
◆英語タイトル:Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5029
◆発行会社(リサーチ会社):MarketLine
◆発行日:2020年2月
◆ページ数:54
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥44,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥67,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or “the company”) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ionis Pharmaceuticals, Inc.: Company Overview
Ionis Pharmaceuticals, Inc.: Overview and Key Facts
Ionis Pharmaceuticals, Inc.: Overview
Ionis Pharmaceuticals, Inc.: Key Facts
Ionis Pharmaceuticals, Inc.: Key Employees
Ionis Pharmaceuticals, Inc.: Key Employee Biographies
Ionis Pharmaceuticals, Inc.: Major Products and Services
Ionis Pharmaceuticals, Inc.: Company History
Ionis Pharmaceuticals, Inc.: Management Statement
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Ionis Pharmaceuticals, Inc.: Key Competitors
Ionis Pharmaceuticals, Inc.: Company Analysis
Ionis Pharmaceuticals, Inc.: Business Description
Ionis Pharmaceuticals, Inc.: SWOT Analysis
Ionis Pharmaceuticals, Inc.: SWOT Overview
Ionis Pharmaceuticals, Inc.: Strengths
Ionis Pharmaceuticals, Inc.: Weaknesses
Ionis Pharmaceuticals, Inc.: Opportunities
Ionis Pharmaceuticals, Inc.: Threats
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Ionis Pharmaceuticals, Inc.: Financial Deals Overview
Ionis Pharmaceuticals, Inc.: Targets and Partners
Ionis Pharmaceuticals, Inc.: Top Deals 2016 – 2020YTD*
Ionis Pharmaceuticals, Inc.: Advisors
Ionis Pharmaceuticals, Inc.: Top Legal Advisors
Ionis Pharmaceuticals, Inc.: Top Financial Advisors
Ionis Pharmaceuticals, Inc.: Corporate Venturing
Ionis Pharmaceuticals, Inc.: Capital Raising
Ionis Pharmaceuticals, Inc.: Partnership
Ionis Pharmaceuticals, Inc.: Private Equity and Ownership
Ionis Pharmaceuticals, Inc.: Recent Developments
Ionis Pharmaceuticals, Inc.: News and Events Summary
Ionis Pharmaceuticals, Inc.: Business Expansion
Ionis Pharmaceuticals, Inc.: Contracts
Ionis Pharmaceuticals, Inc.: Corporate Governance
Ionis Pharmaceuticals, Inc.: Financial Deals
Ionis Pharmaceuticals, Inc.: Financial Performance
Ionis Pharmaceuticals, Inc.: Market Developments
Ionis Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Company History
Table 4: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 9: Ionis Pharmaceuticals, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 13: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 20: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 21: Ionis Pharmaceuticals, Inc.: Business Expansion
Table 22: Ionis Pharmaceuticals, Inc.: Contracts
Table 23: Ionis Pharmaceuticals, Inc.: Corporate Governance
Table 24: Ionis Pharmaceuticals, Inc.: Financial Deals
Table 25: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 26: Ionis Pharmaceuticals, Inc.: Market Developments
Table 27: Ionis Pharmaceuticals, Inc.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析(Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆